| Issue Date | Title | Author(s) | Type | Мp-cat. |
| 2022 | Association Between Clinically Meaningful Improvements in Patient-Reported Outcomes and Stringent Measures of Disease Activity in Patients with Psoriatic Arthritis Treated with Upadacitinib Versus Placebo Or Adalimumab: Results from a Phase 3 Trial | Gossec, Laure; Damjanov, Nemanja S; Tsuji, Shigeyoshi; Lertratanakul, Apinya; Lippe, Ralph; Patel, Janki; Zueger, Patrick; De, Vlam K | Conference Paper | |
| 2021 | Association Between Clinically Meaningful Improvements in Patient-Reported Outcomes and Stringent Measures of Disease Activity in Patients with Psoriatic Arthritis Treated with Upadacitinib versus Placebo or Adalimumab: Results from a Phase 3 Trial | Gossec, Laure; Damjanov, Nemanja S; Tsuji, Shigeyoshi; Lertratanakul, Apinya; Lippe, Ralph; Patel, Jayeshkumar; Zueger, Patrick; De, Vlam Kurt | Conference Paper | |
| 2021 | Improvement in Patient-Reported Outcomes in Patients With Psoriatic Arthritis With Inadequate Response to Non-Biologic DMARDs Treated With Upadacitinib Versus Placebo or Adalimumab: Results From a Phase 3 Study | Gladman, Dafna; Mease, Philip; Soriano, Enrique; Kishimoto, Mitsumasa; Salvarani, Carlo; Damjanov, Nemanja S; Anderson, Jaclyn K; Blondell, Erin; Zueger, Patrick; Saffore, Christopher;
Strand, Vibeke;
| Conference Paper | |
| 2020 | Improvement in Patient-Reported Outcomes in Patients with Psoriatic Arthritis with Inadequate Response to Non-Biologic DMARDs Treated with Upadacitinib versus Placebo or Adalimumab: Results from a Phase 3 Study | Strand, Vibeke; Mease, Philip; Soriano, Enrique; Kishimoto, Mitsumasa; Salvarani, Carlo; Damjanov, Nemanja S; Anderson, Jaclyn K; Blondell, Erin; Zueger, Patrick; Saffore, Christopher;
Gladman, Dafna;
| Conference Paper | |